Preclinical Results Database

Scientific due diligence in preclinical development plays a pivotal role in the success of drug candidates as they progress toward clinical trials. A well-chosen preclinical model is essential for accurately predicting how a drug will behave in humans, reducing both time and financial risks associated with later-stage failures. By thoroughly evaluating potential models for their relevance and translatability, our tool enables Pharmaceutical companies and investors to better understand a compound's safety, efficacy, and potential toxicity early in the development process. This strategic selection minimizes the risk of unforeseen issues, improving the likelihood of positive outcomes in clinical trials.